Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06128720 · ClinicalTrials.gov registry record · NA
Hyperbaric Oxygen Therapy for Optic Neuropathies
A NA study of Glaucoma and Optic Neuropathy, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06128720: Recruiting NA study of Glaucoma and Optic Neuropathy, sponsored by Stanford University.
NCT06128720 is a NA study of Glaucoma and Optic Neuropathy that is actively recruiting participants, run by Stanford University. The registered enrollment target is 60 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06128720, a NA study of Glaucoma and Optic Neuropathy, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to evaluate the neuroprotective efficacy of hyperbaric oxygen for the treatment in patients with optic neuropathy.
Primary Outcome
Humphrey visual field testing with standard MD output
Conditions Studied
Interventions
- DEVICE Hyperbaric Oxygen
- DEVICE Sham Hyperbaric Oxygen
Study Locations (1)
California
- Byers Eye Institute - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT06128720 shows while recruiting
NCT06128720 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Glaucoma appearing as the primary indexed condition, and to 2 interventions - of which Hyperbaric Oxygen is the first listed.
NCT06128720 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06128720 about?
NCT06128720 is a clinical study titled "Hyperbaric Oxygen Therapy for Optic Neuropathies". The purpose of the study is to evaluate the neuroprotective efficacy of hyperbaric oxygen for the treatment in patients with optic neuropathy.
What is the current status of trial NCT06128720?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2022-11-01. Estimated completion is 2027-12.
What conditions does trial NCT06128720 study?
This clinical trial studies the following conditions: Glaucoma, Optic Neuropathy.
What interventions are being tested in trial NCT06128720?
The interventions under investigation include: Hyperbaric Oxygen (DEVICE), Sham Hyperbaric Oxygen (DEVICE).
Who is sponsoring clinical trial NCT06128720?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06128720 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06128720's enrollment target sits among peer trials
60 53rd of 92 higher than 35 of 92 other Glaucoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Tolerability of an Anesthesia-free Tonometer Tip
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Optic Neuropathies
RECRUITING · NA
-
The Role of Music in Enhancing Attention During Visual Field Exams for Pediatric Glaucoma Patients
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Glaucoma
RECRUITING · NA
-
Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI